Edesa Biotech, Inc. (EDSA)
NASDAQ: EDSA · Real-Time Price · USD
7.14
+0.62 (9.51%)
At close: Mar 9, 2026, 4:00 PM EDT
7.27
+0.13 (1.82%)
After-hours: Mar 9, 2026, 7:59 PM EDT
Edesa Biotech Balance Sheet
Financials in millions USD. Fiscal year is October - September.
Millions USD. Fiscal year is Oct - Sep.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2017 |
|---|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Sep '25 Sep 30, 2025 | Sep '24 Sep 30, 2024 | Sep '23 Sep 30, 2023 | Sep '22 Sep 30, 2022 | Sep '21 Sep 30, 2021 | 2020 - 2017 |
| Cash & Equivalents | 12.05 | 10.79 | 1.04 | 5.36 | 7.09 | 7.84 | Upgrade
|
| Cash & Short-Term Investments | 12.05 | 10.79 | 1.04 | 5.36 | 7.09 | 7.84 | Upgrade
|
| Cash Growth | 670.82% | 940.39% | -80.65% | -24.39% | -9.55% | 8.67% | Upgrade
|
| Other Receivables | 0.43 | 0.64 | 0.27 | 0.63 | 1.26 | 3.3 | Upgrade
|
| Receivables | 0.43 | 0.64 | 0.27 | 0.63 | 1.26 | 3.3 | Upgrade
|
| Prepaid Expenses | 0.23 | 0.08 | 0.37 | 0.45 | 0.75 | 0.95 | Upgrade
|
| Total Current Assets | 12.72 | 11.51 | 1.68 | 6.44 | 9.09 | 12.09 | Upgrade
|
| Property, Plant & Equipment | - | - | 0.02 | 0.1 | 0.03 | 0.11 | Upgrade
|
| Other Intangible Assets | 1.95 | 1.98 | 2.08 | 2.18 | 2.28 | 2.38 | Upgrade
|
| Other Long-Term Assets | 0.04 | 0.04 | 0.04 | 0.17 | 0.17 | - | Upgrade
|
| Total Assets | 14.71 | 13.53 | 3.81 | 8.89 | 11.58 | 14.58 | Upgrade
|
| Accounts Payable | 0.76 | 1.08 | 1.81 | 1.75 | 2.12 | 1.38 | Upgrade
|
| Current Portion of Leases | - | - | 0.02 | 0.07 | 0.02 | 0.08 | Upgrade
|
| Total Current Liabilities | 0.76 | 1.08 | 1.83 | 1.82 | 2.14 | 1.46 | Upgrade
|
| Long-Term Leases | - | - | - | 0.02 | - | 0.02 | Upgrade
|
| Other Long-Term Liabilities | - | - | - | - | 0.04 | 0.05 | Upgrade
|
| Total Liabilities | 0.76 | 1.08 | 1.83 | 1.84 | 2.18 | 1.53 | Upgrade
|
| Common Stock | 57.9 | 54.52 | 47.24 | 46.64 | 42.47 | 34.89 | Upgrade
|
| Additional Paid-In Capital | 15.12 | 14.75 | 13.58 | 13.04 | 11.18 | 4.87 | Upgrade
|
| Retained Earnings | -68.2 | -65.91 | -58.59 | -52.42 | -44.04 | -26.5 | Upgrade
|
| Comprehensive Income & Other | -0.17 | -0.17 | -0.24 | -0.21 | -0.21 | -0.21 | Upgrade
|
| Total Common Equity | 4.66 | 3.19 | 1.98 | 7.05 | 9.39 | 13.06 | Upgrade
|
| Shareholders' Equity | 13.95 | 12.45 | 1.98 | 7.05 | 9.39 | 13.06 | Upgrade
|
| Total Liabilities & Equity | 14.71 | 13.53 | 3.81 | 8.89 | 11.58 | 14.58 | Upgrade
|
| Total Debt | - | - | 0.02 | 0.09 | 0.02 | 0.1 | Upgrade
|
| Net Cash (Debt) | 12.05 | 10.79 | 1.02 | 5.27 | 7.07 | 7.74 | Upgrade
|
| Net Cash Growth | 670.82% | 960.70% | -80.68% | -25.52% | -8.63% | 9.79% | Upgrade
|
| Net Cash Per Share | 1.76 | 1.90 | 0.32 | 1.84 | 3.37 | 4.49 | Upgrade
|
| Filing Date Shares Outstanding | 8.35 | 8.33 | 3.47 | 3.16 | 2.76 | 1.93 | Upgrade
|
| Total Common Shares Outstanding | 8.33 | 7.14 | 3.25 | 3.08 | 2.38 | 1.9 | Upgrade
|
| Working Capital | 11.96 | 10.43 | -0.16 | 4.61 | 6.95 | 10.63 | Upgrade
|
| Book Value Per Share | 0.56 | 0.45 | 0.61 | 2.29 | 3.95 | 6.88 | Upgrade
|
| Tangible Book Value | 2.7 | 1.21 | -0.1 | 4.87 | 7.11 | 10.68 | Upgrade
|
| Tangible Book Value Per Share | 0.32 | 0.17 | -0.03 | 1.58 | 2.99 | 5.62 | Upgrade
|
| Machinery | - | - | - | 0.05 | 0.05 | 0.05 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.